IP Library › Granted Patent US 10,675,273
Granted Patent B2
US 10,675,273 · App. 16/066,285 · Granted Jun 9, 2020

Benzothiazole amphiphiles

Inventor: Jerry Yang (La Jolla, CA)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
A61K31/426A61K47/10A61P25/00A61P35/00C07D277/66
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,675,273
App. No.
16/066,285
Granted
Jun 9, 2020
Kind
B2
Abstract

Disclosed herein, inter alia, are compounds and methods for increasing spine density in a neuron, and for treatment of neuronal diseases and cancer.

Claims (20)

1. A compound having the formula (I):

wherein

R 1 is independently

halogen, —CX 1 3 , —CHX 1 2 , —CH 2 X 1 , —OCX 1 3 , —OCHX 1 2 , —OCH 2 X 1 , —CN, —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC(O)NHNH 2 , NHC(O)NH 2 , —NHSO 2 H, —NHC(O)H, —NHC(O)OH, —NHOH, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R 2 is independently

halogen, —CX 2 3 , —CHX 2 2 , —CH 2 X 2 , —OCX 2 3 , —OCHX 2 2 , —OCH 2 X 2 , —CN, —OH, —NH 2 , —COOH, —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC(O)NHNH 2 , —NHC(O)NH 2 , —NHSO 2 H, —NHC(O)H, —NHC(O)OH, —NHOH, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

X 1 and X 2 are independently halogen;

z1 and z2 are independently an integer from 0 to 4; and

n is an integer from 1 to 12.

2. The compound of claim 1 , wherein R 1 is substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

3. The compound of claim 1 , wherein R 1 is substituted or unsubstituted alkyl.

4. The compound of claim 1 , wherein R 2 is substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

5. The compound of claim 1 , wherein R 2 is substituted or unsubstituted alkyl.

6. The compound of claim 1 , wherein z1 is 0 or 1.

7. The compound of claim 1 , wherein z1 is 0.

8. The compound of claim 1 , wherein z2 is 0.

9. The compound of claim 1 , wherein n is 3 to 8.

10. The compound of claim 1 , wherein n is 3 to 5.

11. The compound of claim 1 , having the formula:

12. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2019
From: YANG, JERRY
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 049141/0350 →
Continuity (2)
Provisional Application 62274907 · Jan 5, 2016
Related Publication 20190000811A1 · Jan 3, 2019
Cited By (3)
US 12,391,659 US 12,486,287 US 12,734,159